PTC Therapeutics, Inc.

Pharmaceutical company · Warren, New Jersey, United States · Nasdaq: PTCT

PTC Therapeutics, Inc. is a pharmaceutical company headquartered in Warren, New Jersey, United States. Its shares trade on Nasdaq under the ticker PTCT. It has received 16 US government small-business research awards (SBIR/STTR) from health agencies, $6.2 million in total, most recently in 2006. It has reported private securities offerings to the US SEC, most recently $36 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

PTC Therapeutics at a glance

Typepharmaceutical company
HeadquartersWarren, New Jersey, United States
Stock listingNasdaq: PTCT
SEC industryPharmaceutical Preparations
SEC CIK1070081

What does PTC Therapeutics do?

US government research funding

16 SBIR/STTR small-business research awards from US health agencies, $6.2 million in total (2000 to 2006).

Private fundraising reported to the SEC

10 Form D notices; the most recent reported $35.9 million sold (2023).

Frequently asked questions about PTC Therapeutics

Where is PTC Therapeutics headquartered?

PTC Therapeutics, Inc. is headquartered in Warren, New Jersey, United States.

What does PTC Therapeutics do?

PTC Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is PTC Therapeutics a public company?

Yes. PTC Therapeutics, Inc. trades on Nasdaq under the ticker PTCT.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.